DK0883619T3 - Morfin- og diamorfinsalte af anioniske ikke-narkotiske analgetika af substitueret carboxylsyretype - Google Patents

Morfin- og diamorfinsalte af anioniske ikke-narkotiske analgetika af substitueret carboxylsyretype

Info

Publication number
DK0883619T3
DK0883619T3 DK97903288T DK97903288T DK0883619T3 DK 0883619 T3 DK0883619 T3 DK 0883619T3 DK 97903288 T DK97903288 T DK 97903288T DK 97903288 T DK97903288 T DK 97903288T DK 0883619 T3 DK0883619 T3 DK 0883619T3
Authority
DK
Denmark
Prior art keywords
salts
substituted carboxylic
morphine
pct
narcotic analgesics
Prior art date
Application number
DK97903288T
Other languages
English (en)
Inventor
Bodo Asmussen
Walter Mueller
Walter Riess
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK0883619T3 publication Critical patent/DK0883619T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97903288T 1996-02-28 1997-02-15 Morfin- og diamorfinsalte af anioniske ikke-narkotiske analgetika af substitueret carboxylsyretype DK0883619T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19607395A DE19607395C2 (de) 1996-02-28 1996-02-28 Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate
PCT/EP1997/000711 WO1997031918A1 (de) 1996-02-28 1997-02-15 Morphin- und diamorphinsalze anionischer nicht-narkotischer analgetika vom typ der substituierten carbonsäuren

Publications (1)

Publication Number Publication Date
DK0883619T3 true DK0883619T3 (da) 2002-04-29

Family

ID=7786595

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97903288T DK0883619T3 (da) 1996-02-28 1997-02-15 Morfin- og diamorfinsalte af anioniske ikke-narkotiske analgetika af substitueret carboxylsyretype

Country Status (20)

Country Link
US (1) US6156764A (da)
EP (1) EP0883619B1 (da)
JP (1) JP4624497B2 (da)
KR (1) KR100422276B1 (da)
CN (1) CN1064363C (da)
AT (1) ATE212024T1 (da)
AU (1) AU712255B2 (da)
CZ (1) CZ294401B6 (da)
DE (2) DE19607395C2 (da)
DK (1) DK0883619T3 (da)
ES (1) ES2171886T3 (da)
HU (1) HU225268B1 (da)
IL (1) IL125819A (da)
NO (1) NO983864L (da)
NZ (1) NZ331485A (da)
PL (1) PL185915B1 (da)
PT (1) PT883619E (da)
SK (1) SK104398A3 (da)
WO (1) WO1997031918A1 (da)
ZA (1) ZA971740B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1017696E (pt) * 1997-09-25 2002-09-30 Lohmann Therapie Syst Lts Sais de adicao de acido de alcaloides de morfina e sua utilizacao
CA2448665C (en) * 2001-06-05 2013-01-29 Control Delivery Systems Sustained-release analgesic compounds
CA2463758A1 (en) * 2001-10-18 2003-05-01 Novartis Ag Salts formed of an at1-receptor antagonist and a cardiovascular agent
AU2002350207A1 (en) * 2001-11-19 2003-06-10 Control Delivery Systems, Inc. Topical delivery of codrugs
WO2003061626A1 (en) * 2002-01-18 2003-07-31 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
US8840928B2 (en) * 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2004004693A1 (en) * 2002-07-05 2004-01-15 Collgegium Pharmaceutical Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8557291B2 (en) 2002-07-05 2013-10-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opioids and other drugs
TW200500067A (en) * 2003-01-21 2005-01-01 Control Delivery Sys Inc Salts of codrugs and uses related thereto
ATE536861T1 (de) 2003-06-26 2011-12-15 Control Delivery Sys Inc Bioerodierbare arzneimittelabgabesysteme mit verzögerter freisetzung
AR044926A1 (es) 2003-06-26 2005-10-12 Control Delivery Sys Inc Sistema de suministro de farmacos gelificante in situ
EP1686963A1 (en) * 2003-10-27 2006-08-09 PSivida Inc. Suspension delivery system for the sustained and controlled local release of pharmaceuticals
CA2569958C (en) 2004-06-12 2016-03-22 Jane C. Hirsh Abuse-deterrent drug formulations
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404209A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and sulindac
GB8319546D0 (en) * 1983-07-20 1983-08-24 Euro Celtique Sa Pharmaceutical active salts
ZA893422B (en) * 1988-02-24 1991-01-30 Adcock Ingram Lab Ltd Pharmaceutical composition
TW225536B (da) * 1990-08-23 1994-06-21 Ciba Geigy Ag
EP0574424A1 (en) * 1991-03-04 1993-12-22 Warner-Lambert Company Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
US5256669A (en) * 1992-08-07 1993-10-26 Aminotek Sciences, Inc. Methods and compositions for treating acute or chronic pain and drug addiction
SE9301057L (sv) * 1993-03-30 1994-10-01 Pharmacia Ab Beredning med kontrollerad frisättning
FR2708611B1 (fr) * 1993-07-29 1995-10-27 Meram Lab Sel de codéine de l'acide 2-(3-benzoylphényl)propionique, procédé d'obtention et compositions pharmaceutiques le contenant.
GB9319568D0 (en) * 1993-09-22 1993-11-10 Euro Celtique Sa Pharmaceutical compositions and usages
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy

Also Published As

Publication number Publication date
PL185915B1 (pl) 2003-08-29
NO983864D0 (no) 1998-08-21
EP0883619A1 (de) 1998-12-16
HUP9900568A3 (en) 2001-08-28
NZ331485A (en) 1999-03-29
IL125819A0 (en) 1999-04-11
CN1064363C (zh) 2001-04-11
PL328712A1 (en) 1999-02-15
CZ265798A3 (cs) 1998-11-11
EP0883619B1 (de) 2002-01-16
JP2000505463A (ja) 2000-05-09
KR100422276B1 (ko) 2004-07-30
NO983864L (no) 1998-08-21
ES2171886T3 (es) 2002-09-16
DE19607395A1 (de) 1997-09-04
HUP9900568A2 (hu) 1999-06-28
CZ294401B6 (cs) 2004-12-15
PT883619E (pt) 2002-07-31
IL125819A (en) 2002-04-21
KR19990087343A (ko) 1999-12-27
ATE212024T1 (de) 2002-02-15
AU712255B2 (en) 1999-11-04
ZA971740B (en) 1997-09-04
HU225268B1 (en) 2006-08-28
US6156764A (en) 2000-12-05
JP4624497B2 (ja) 2011-02-02
SK104398A3 (en) 1998-12-02
DE59706015D1 (de) 2002-02-21
DE19607395C2 (de) 2002-11-21
AU1769597A (en) 1997-09-16
WO1997031918A1 (de) 1997-09-04
CN1212698A (zh) 1999-03-31

Similar Documents

Publication Publication Date Title
DK0883619T3 (da) Morfin- og diamorfinsalte af anioniske ikke-narkotiske analgetika af substitueret carboxylsyretype
NO2006007I1 (no) (+)-(S)-2-(3-benzoylfenyl)-propionsyre-trometaminsalt(deksketoprofentrometamol)
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
ATE325128T1 (de) Substituierte aminoalkanphosphonsäuren
BR9406941A (pt) Formulação oral com revestimento entèrico processo para a preparação da formulação processo para a inibição da secreção de acido gástrico em mamiferos e no homem e processo para o tratamento de doencas relacionados ao ácidos gástrico em mamiferos e no homem
YU57599A (sh) Primena derivata fumarne kiseline
DK0760661T3 (da) Farmaceutiske sammensætninger omfattende en opiat-antagonist og calciumsalte, deres anvendelse til behandling af endorfin-m
SE9401728D0 (sv) New compounds II
NO982778L (no) Morfinderivater med smertestillende virkning
IT1293305B1 (it) Sali di acidi difosfonici e loro impiego farmacologico nel trattamento dell'osteoporosi
FI964582A (fi) Aminosulfonihappojohdannaisia, niiden käyttö pseudopeptidisynteesissä ja menetelmä niiden valmistamiseksi
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
NO983103D0 (no) Nye monofunksjonelle EDTA-, DTPA- og TTHA-derivater og deres anvendelse i medisinsk diagnostikk og terapi
BR9911969A (pt) Sal e processos para a preparação de um sal, para a preparação de acetato de n-terc-butilhidroxilamina, para o isolamento de acetato de n-terc- butilhidroxilamina, e para a purificação do acetato de n-terc- butilhidroxilamina
CA2247616A1 (en) Morphine and diamorphine salts of anionic non-narcotic analgesics of the substituted carboxylic acid type
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
SE9404438D0 (sv) New process
DK0891322T3 (da) Dimethylsubstituerede cyclohexandienderivater
ATE221068T1 (de) Anellierte beta-carboline
DE59605367D1 (de) Verwendung des alpha,alpha-diphenylessigsäure-4-(n-methyl-piperidyl)esters als spasmoanalgetikum